Join special guest host Adam Robinson, Owner of Save-Rite Drugs in Lexington, Kentucky on a multi-episode journey recapping all things Retail Business Conference! Listen in for highlights of Cardinal Health customers, employees, services and solutions offered at RBC 2024! This episode’s topic includes Cardinal Health™ Reconciliation. Learn how this solution can provide clear visibility into your pending claims, as well as total reconciled claims.

Each year, the National Community Pharmacists Association (NCPA), in partnership with Cardinal Health, publishes the NCPA Digest, a comprehensive analysis quantifying and profiling the state of independent community pharmacy. The Digest is designed to help pharmacy owners better manage their business and provide elected officials with data to inform policymaking. Cardinal Health has been a proud sponsor of this annual report since 2008, reiterating our commitment to independent pharmacies and their ongoing success as community healthcare destinations. In this episode, Doug Hoey, CEO of NCPA, and Lisa Schwartz, NCPA’s senior director of professional affairs, discuss findings from the 2024 edition of the NCPA Digest with Brad Cochran, executive vice president, pharmaceutical and specialty distribution at Cardinal Health. From patient care services and technological trends to economic impacts and the importance of advocacy, Doug, Lisa and Brad explain how the 2024 NCPA Digest can help independent pharmacists benchmark current business performance and adopt new strategies. Access the Digest here or log in to your NCPA member profile. In this episode, Doug Hoey, CEO of NCPA, and Lisa Schwartz, NCPA’s senior director of professional affairs, discuss findings from the 2024 edition of the NCPA Digest with Brad Cochran, executive vice president, pharmaceutical and specialty distribution at Cardinal Health. From patient care services and technological trends to economic impacts and the importance of advocacy, Doug, Lisa and Brad explain how the 2024 NCPA Digest can help independent pharmacists benchmark current business performance and adopt new strategies.

Access the Digest here or log in to your NCPA member profile.

Educational Objectives

• Review recent clinical updates of RET inhibitors and how they fit into the treatment paradigm for non‒small cell lung cancer
• Identify and manage adverse effects of RET inhibitors to ensure patient safety and improve adherence

Faculty

Lauren Ledbetter, PharmD, BCOP

Clinical Pharmacy Specialist, Thoracic Medical Oncology

The James Cancer Hospital at The Ohio State University

Columbus, Ohio

Moderator

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Clinical Pharmacy Manager

University of Kansas Cancer Center

Division of Hematologic Malignancies & Cellular Therapeutics

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.5 CEU) under the ACPE universal activity number 0290-0000-24-304-H01-P. The activity is available for CE credit through October 31, 2025.

This activity is supported by an educational grant from Rigel Pharmaceuticals, Inc.